Literature DB >> 30273623

PCR cycle threshold to assess a diagnostic stewardship intervention for C. difficile testing.

Gregory R Madden1, Melinda D Poulter2, Costi D Sifri3.   

Abstract

Entities:  

Keywords:  Clostridium difficile; Diagnostic error; Diagnostic stewardship

Mesh：

Year:  2018        PMID： 30273623      PMCID： PMC7041366          DOI： 10.1016/j.jinf.2018.09.013

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  6 in total

1.  Clostridium difficile PCR Cycle Threshold Predicts Free Toxin.

Authors:  Fiona Senchyna; Rajiv L Gaur; Saurabh Gombar; Cynthia Y Truong; Lee F Schroeder; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-06-14       Impact factor: 5.948

2.  Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer.

Authors:  Mini Kamboj; Jennifer Brite; Tracy McMillen; Elizabeth Robilotti; Alejandro Herrera; Kent Sepkowitz; N Esther Babady
Journal:  J Infect       Date:  2017-12-08       Impact factor: 6.072

3.  Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.

Authors:  Christopher R Polage; Clare E Gyorke; Michael A Kennedy; Jhansi L Leslie; David L Chin; Susan Wang; Hien H Nguyen; Bin Huang; Yi-Wei Tang; Lenora W Lee; Kyoungmi Kim; Sandra Taylor; Patrick S Romano; Edward A Panacek; Parker B Goodell; Jay V Solnick; Stuart H Cohen
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

4.  Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?

Authors:  Mark I Garvey; Craig W Bradley; Martyn A C Wilkinson; Elisabeth Holden
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-19       Impact factor: 4.887

Review 5.  Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications.

Authors:  Luis Furuya-Kanamori; John Marquess; Laith Yakob; Thomas V Riley; David L Paterson; Niki F Foster; Charlotte A Huber; Archie C A Clements
Journal:  BMC Infect Dis       Date:  2015-11-14       Impact factor: 3.090

6.  Reduced Clostridium difficile Tests and Laboratory-Identified Events With a Computerized Clinical Decision Support Tool and Financial Incentive.

Authors:  Gregory R Madden; Ian German Mesner; Heather L Cox; Amy J Mathers; Jason A Lyman; Costi D Sifri; Kyle B Enfield
Journal:  Infect Control Hosp Epidemiol       Date:  2018-04-12       Impact factor: 3.254
  6 in total
  4 in total

1.  The Role of Diagnostic Stewardship in Clostridioides difficile Testing: Challenges and Opportunities.

Authors:  Frances J Boly; Kimberly A Reske; Jennie H Kwon
Journal:  Curr Infect Dis Rep       Date:  2020-02-17       Impact factor: 3.725

2.  IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection.

Authors:  Alyse L Frisbee; Mahmoud M Saleh; Mary K Young; Jhansi L Leslie; Morgan E Simpson; Mayuresh M Abhyankar; Carrie A Cowardin; Jennie Z Ma; Patcharin Pramoonjago; Stephen D Turner; Alice P Liou; Erica L Buonomo; William A Petri
Journal:  Nat Commun       Date:  2019-06-20       Impact factor: 14.919

3.  Patient Outcomes With Prevented vs Negative Clostridioides difficile Tests Using a Computerized Clinical Decision Support Tool.

Authors:  Gregory R Madden; Kyle B Enfield; Costi D Sifri
Journal:  Open Forum Infect Dis       Date:  2020-03-18       Impact factor: 3.835

4.  Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis.

Authors:  Gregory R Madden; David C Smith; Melinda D Poulter; Costi D Sifri
Journal:  Open Forum Infect Dis       Date:  2020-12-21       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.